Your search returned 18 studies. (Get alerts for new studies):
- A Dose Finding and Safety Study of Oral LDE225 in Children
Conditions: Medulloblastoma, - Rhabdomyosarcoma, - Neuroblastoma, - Hepatoblastoma, - High Grade Glioma, - Astrocytoma
4 Locations available
- Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial
Conditions: Brain and Central Nervous System Tumors
142 Locations available
- Methionine PET/CT Studies In Patients With Cancer
Conditions: Brain Tumors and /or Solid Tumors Including: - Brain Stem Glioma - High Grade CNS Tumors - Ependymoma - Medulloblastoma - Craniopharyngioma - Low Grade CNS Tumors - Hodgkin Lymphoma - Non Hodgkin Lymphoma - Ewing Sarcoma - Osteosarcoma - Rhabdomyosarcoma
1 Location available
- Natural History of Patients With Brain and Spinal Cord Tumors
Conditions: Astrocytoma - Central Nervous System Tumor - Glioblastoma - Glioma - Medulloblastoma
1 Location available
- Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors - Chemotherapeutic Agent Toxicity - Cognitive/Functional Effects - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity - Therapy-related Toxicity
99 Locations available
- Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma
Conditions: Brain Tumor - Medulloblastoma - Pineoblastoma
2 Locations available
- Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma - Medulloblastoma
7 Locations available
- GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- GDC-0449 in Treating Adult Patients With Recurrent or Refractory Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
6 Locations available
- Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor (PNET)
Conditions: Medulloblastoma - Neuroectodermal Tumors
1 Location available
- Concurrent Carboplatin and Reduced Dose Craniospinal Radiation for Medulloblastoma and PNET
Conditions: Metastatic Medulloblastoma - High Risk Supratentorial PNET - Metastatic PNET
1 Location available
- A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
Conditions: Advanced Solid Tumors - Recurrent or Refractory Medulloblastoma - Locally Advanced or Metastatic Basal Cell Carcinoma
2 Locations available
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS P
Conditions: Brain and Central Nervous System Tumors
84 Locations available
- GDC-0449 in Treating Younger Patients With Recurrent or Refractory Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
11 Locations available
- Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
Conditions: Neuroblastoma - Medulloblastoma
5 Locations available
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Conditions: Ewing's Sarcoma - Osteosarcoma - Astrocytoma - Atypical Teratoid/Rhabdoid Tumor - Ependymoma - Germ Cell Tumor - Glioma - Medulloblastoma - Rhabdoid Tumor - Retinoblastoma - Clear Cell Sarcoma - Renal Cell Carcinoma - Wilms Tumor - Hepatoblastoma - Neurob
1 Location available
|